For the fourth time, ISCT has been featured prominently in the Cell and Gene Therapy Supplement, published annually by The Medicine Maker.
Despite the challenges of 2020, ISCT continues its prominent role in the translation of Cell and Gene Therapies, and looks forward to the opportunities 2021 will bring!
About the Medicine Maker
Founded in 2007, The Medicine Maker is a global magazine dedicated to bio and pharmaceutical development and manufacturing. With a readership of over 180,000 international subscribers, it focuses on news and interviews with the greats of the life science field, from regulators (FDA) to international societies, to top pharma CEOs. The Medicine Maker explores the story behind the story - not just what is happening, but why, how, who, where, when, and how a story will affect different stakeholders in the wider industry. The CGT supplement is, one of the key annual public summaries of the CGT sector, read by stakeholders across the field. This is the 4th concurrent CGT supplement with central ISCT contribution.#News